USANA Health Sciences (NYSE:USNA) Hits New 12-Month Low - Here's What Happened

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report)'s stock price reached a new 52-week low during trading on Thursday . The stock traded as low as $35.63 and last traded at $35.81, with a volume of 4493 shares trading hands. The stock had previously closed at $36.39.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on USNA shares. DA Davidson decreased their price objective on shares of USANA Health Sciences from $46.00 to $38.00 and set a "neutral" rating for the company in a report on Thursday, July 25th. StockNews.com lowered shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, July 24th.

USANA Health Sciences Trading Down 2.7 %

The business has a fifty day simple moving average of $39.52 and a two-hundred day simple moving average of $43.79. The stock has a market cap of $674.31 million, a PE ratio of 11.26, a P/E/G ratio of 1.27 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share for the quarter, missing analysts' consensus estimates of $0.65 by ($0.11). The business had revenue of $212.87 million during the quarter, compared to analysts' expectations of $218.64 million. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. During the same period last year, the firm posted $0.89 EPS. On average, research analysts predict that USANA Health Sciences, Inc. will post 2.5 earnings per share for the current year.

Insider Activity

In related news, Director Gilbert A. Fuller sold 674 shares of the firm's stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other USANA Health Sciences news, Director Gilbert A. Fuller sold 674 shares of the firm's stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total value of $26,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John Turman Fleming sold 1,000 shares of the firm's stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $44.43, for a total transaction of $44,430.00. Following the transaction, the director now directly owns 2,503 shares in the company, valued at $111,208.29. The disclosure for this sale can be found here. Insiders have sold 7,940 shares of company stock worth $311,670 in the last three months. Company insiders own 0.33% of the company's stock.

Institutional Investors Weigh In On USANA Health Sciences

Several hedge funds have recently added to or reduced their stakes in USNA. CWM LLC increased its stake in shares of USANA Health Sciences by 21.8% in the 1st quarter. CWM LLC now owns 1,543 shares of the company's stock worth $75,000 after acquiring an additional 276 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of USANA Health Sciences by 9.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company's stock worth $284,000 after acquiring an additional 494 shares in the last quarter. Public Sector Pension Investment Board raised its position in USANA Health Sciences by 5.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company's stock valued at $1,098,000 after purchasing an additional 1,242 shares in the last quarter. State Board of Administration of Florida Retirement System lifted its stake in USANA Health Sciences by 22.7% in the first quarter. State Board of Administration of Florida Retirement System now owns 8,430 shares of the company's stock worth $409,000 after acquiring an additional 1,560 shares during the last quarter. Finally, First Hawaiian Bank raised its stake in USANA Health Sciences by 22.3% in the first quarter. First Hawaiian Bank now owns 9,089 shares of the company's stock valued at $441,000 after buying an additional 1,656 shares in the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.